Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha 3 subunit-containing complex (GABA_A receptor α3βxγ2) (GABA_A receptor α3βxγ2)

Target
GABA_A receptor α3βxγ2
Molecular classification
Ion channel, Ligand-gated ion channel, GABA receptor, Pentameric ligand-gated ion channel
01

Overview

The Gamma-aminobutyric acid type A (GABA_A) receptor α3βxγ2 is a subtype of the pentameric ligand-gated ion channel responsible for mediating fast inhibitory neurotransmission in the mammalian central nervous system (UniProt P34903). It is typically composed of two α3 subunits, two β subunits (β2 or β3), and one γ2 subunit, which together form a chloride-selective pore (PMID: 11689411). This receptor subtype is predominantly expressed in the thalamus, amygdala, and the dorsal horn of the spinal cord, where it plays a crucial role in modulating sensory input and emotional responses (PMID: 21606318). Dysregulation of α3-containing GABA_A receptors is implicated in the pathophysiology of chronic neuropathic pain, generalized anxiety disorders, and certain types of epilepsy (PMID: 15620363). Therapeutic targeting of this receptor involves positive allosteric modulators (PAMs) that bind to the benzodiazepine site at the α3/γ2 interface, enhancing the inhibitory effect of GABA (PubChem CID 3016). Unlike α1-containing receptors which mediate sedation, α3-containing receptors are primarily associated with anxiolytic and analgesic effects (PMID: 19012749). Consequently, drug discovery efforts are focused on developing α3-selective or α2/α3-preferring modulators to treat pain and anxiety while minimizing sedative side effects (PMID: 29351434). These receptors also interact with various endogenous neurosteroids and barbiturates, which further modulate their channel kinetics and inhibitory tone (StatPearls NBK526124).

Other names
α3-GABA_A receptorGABRA3-containing GABA_A receptorGABA(A) receptor alpha 3 beta gamma 2Alpha-3-containing GABA-A receptor
02

Mechanism of action

Positive allosteric modulation of the GABA_A receptor at the benzodiazepine binding site located at the α3/γ2 subunit interface, which increases the frequency of chloride channel opening in response to GABA binding, leading to neuronal hyperpolarization (PMID: 15620363, StatPearls NBK526124).

03

Biological functions

Inhibitory neurotransmission (UniProt P34903)Chloride transport (StatPearls NBK526124)Hyperpolarization (PMID: 11689411)Signal transduction (UniProt P34903)Synaptic inhibition (PMID: 21606318)
04

Disease associations

Neuropathic pain (PMID: 21606318)Generalized anxiety disorder (PMID: 15620363)Epilepsy (PMID: 25485137)Schizophrenia (PMID: 22300105)Sleep disorders (PMID: 11689411)Chronic pain (PMID: 19012749)
05

Safety considerations

Sedation (if α1 selectivity is lost) (PMID: 15620363)Ataxia (PMID: 11024220)Tolerance development (StatPearls NBK526124)Physical dependence (PubChem CID 3016)Withdrawal symptoms (StatPearls NBK526124)Cognitive impairment (PMID: 19012749)
06

Interacting drugs

Diazepam (PubChem CID 3016)

7 more in the full profile.

07

Biomarkers

EEG beta-band power (PMID: 25324369)PET imaging with [11C]flumazenil (PMID: 10443567)Saccadic eye movement (as a measure of non-selectivity/sedation) (PMID: 15620363)

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha 3 subunit-containing complex (GABA_A receptor α3βxγ2) (GABA_A receptor α3βxγ2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha 3 subunit-containing complex (GABA_A receptor α3βxγ2) (GABA_A receptor α3βxγ2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call